Parametric Portfolio Associates’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
RCM
AC
WA
RI
PA
Parametric Portfolio Associates's MGNX Position: Q1 2022 in Review
Parametric Portfolio Associates increased its MacroGenics (MGNX) stake by 7.1% in Q1 2022, buying an estimated $30.1K and bringing the position to 41,280 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.
Parametric Portfolio Associates first reported a position in MGNX in Q2 2017 and has held it in 20 quarters since. The position peaked at $2.67M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.
- Parametric Portfolio Associates held 41,280 shares of MacroGenics worth $364K as of Q1 2022.
- Parametric Portfolio Associates bought 2,728 MacroGenics shares in Q1 2022, an estimated $30.1K.
- MacroGenics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3218 holding.
- Parametric Portfolio Associates first reported a position in MacroGenics in Q2 2017 and has held it in 20 quarters since.
- Parametric Portfolio Associates's MacroGenics position peaked at $2.67M in Q1 2021.
- 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.